glp-1 als and Its Role in Glycogen Production: A Narrative Review Repurposing glucagon-like peptide-1 receptor agonists

Recent study results shared at the Endocrine Society meeting ENDO 2026 indicate that semaglutide was linked to higher weight loss and a 15% decrease in broken bones when it was compared to other weight loss medications

The ketogenic component usually involves MCT oil or beta-hydroxybutyrate (BHB) salts intended to elevate blood ketone levels and support metabolic adaptation to a low-carbohydrate diet

10.1016/j.bone.2012.02.003 58 EastellR.SzulcP

These include unexplained weight loss beyond expected therapeutic effects, persistent fever, night sweats, shortness of breath, chest pain, palpitations, or changes in mood such as low mood or anxiety

PMCID: PMC5421125

However, no attempt was made to ascertain if the available number of patients on GLP-1 agonist use or the number of events were enough for definitive conclusions